SlideShare a Scribd company logo
POSOLOGY
By:
VENUGOPAL N
2
2
CONTENTS
• Definition
• Formulas to calculate Child Dose based on
– Age
– Body Weight
– Body Surface Area
• Factors influencing dose
3
3
Definition
Posology is derived from the Greek word
“Posos” meaning how much
“Logos” meaning science.
So posology is the branch of medicine dealing with doses.
i.e., quantity of drugs which can be administered to a patient to get
the desired pharmacological action.
The optimum dose of a drug varies from patient to patient.
4
4
Formulas to calculate child dose
Based on age:
1. Young’s Formula
2. Dilling’s Formula
3. Fried’s Formula
4. Cowling’s Formula
Based on body weight:
1. Clark’s Formula
Based on Surface area:
1. Catzel Formula
2. Mosteller Formula
5
5
AGE
• Neonate: From birth to till 30 days
• Infant: Upto 1 year
• Toddler: 1 - 3 years
• Child: 3 – 12 years
• Adolescent: 13 – 18 years
• Adult
• Geriatrics
6
6
Young’s Formula
7
7
Dilling’s Formula
8
8
Fried’s Formula
9
9
Cowling’s Formula
10
10
Clark’s Formula
11
11
Catzel Formula
12
12
Mosteller Formula
Factors Influencing Dose
1. Age
2. Sex
3. Body Weight
4. Route of Administration
5. Time of Administration
6. Environmental Factors
7. Emotional Factors
8. Presence of Disease
9. Accumulation
10. Additive Effect
11. Synergism
12. Antagonism
13. Idiosyncrasy
14. Tolerance
15. Tachyphylaxis
16. Hypersensitivity
17. Metabolic disturbances
18. Drug dependence
14
14
AGE
• Age of an individual is one of the important factor affecting the
dose and pharmacological action of the drugs.
• Age is considered with the capacity of metabolizing or excreting
the drugs from the body.
• Newborn infants (pediatric) are abnormally sensitive to certain
drugs because of the immature state of their hepatic and renal
function by which drugs are inactivated and eliminated from
the body.
• Failure to detoxify and eliminate drugs results in their
accumulation in the tissues to a toxic level.
15
15
• The decline in renal and hepatic function in the elderly
(geriatric) may slow drug clearance and increases the
possibility of drug accumulation in the body and subsequent
toxicity.
• Elderly individuals may also respond abnormally to the usual
amount of a drug because of changes in drug-receptor
sensitivity or because of age-related alterations in target tissues
and organs.
New Born:
• Chloramphenicol cause grey baby syndrome because of
inadequate metabolism resulting drug accumulation.
• Absorption of Amoxycillin is higher because of less gastric
acidity.
16
16
Children (Paediatrics):
• Need lesser dose than the normal adult dose, because of their
pharmacokinetic profile (metabolism & excretion).
• Children can tolerate relatively larger amounts of belladonna,
digitalis and ethanol whereas, elderly patients are more
sensitive to hypnotics and tranquillizers which may produce
confusion states in them.
• The blood brain barrier (BBB) of children are not well
developed so more sensitive to CNS stimulants.
Adults: Age (18 yrs), weight (70 kg) and BSA (1.7-1.8 m2 )
Old people (Geriatrics, age > 60 yrs):
• Need lesser dose because of their pharmacokinetic profile
• More sensitive to diazepam and morphine
17
17
SEX
• Sex, either male or females affect the dose of the drugs.
• Women do not always respond to the action of the drugs in
same manner as it is done in men.
• Morphine and barbiturates produce more excitement before
sedation in women. Special care must be taken when drugs are
administered during menstruation, pregnancy and lactation.
• The strong purgatives such as aloes should be avoided during
menstruation.
• Drugs which may stimulate the uterine smooth muscles e.g.
drastic purgatives, antimalarial drugs and ergot alkaloids are
contraindicated during pregnancy.
18
18
• During lactation drugs like antihistamines, morphine and
tetracycline are excreted in milk, should be avoided or use
cautiously.
• Alcohol, barbiturate, narcotic drugs acts on fetus through
placenta. Because of the undeveloped drug detoxification and
excretion mechanisms present in the fetus, concentrations of
drugs may reach a higher level in the fetus than in the maternal
circulation.
• The transfer of drugs from the mother to the nursing infant
through human milk may occur with various drugs with the
drug effects becoming manifest in the infant.
19
19
Body Weight
• Weight of the drug is considered as a key factor on the theory
that the concentration of a drug at its site of action will often be
influenced by the size of the patient.
• The average dose is mentioned either in terms of mg/kg body
weight or as total single dose for an adult weighing 70 kg.
• However, in cases of obese patients, children and malnourished
patients the dose differs. It should be calculated according to
the body weight.
20
20
Route of Administration
• They are many routes of administration.
• Route of administration affects therapeutic efficacy of drug.
• Drugs administered intravenously enter the blood stream
directly and thus the full amount administered is present in the
blood.
• In contrast, drugs administered orally are rarely fully absorbed
due to the various physical, chemical and biologic barriers to
their absorption, including interactions with the gastric and
intestinal contents.
• Thus, a lesser parentral dose of a drug is required than the oral
dose to achieve the same blood levels of drug.
21
21
Time of Administration
• The time at which a drug is administered sometimes influences
dosage. This is specially true for oral therapy in relation to
meals.
• The drugs are more rapidly absorbed on empty stomach.
• Absorption proceeds more rapidly if the stomach and upper
portions of the intestinal tract are free of food, and an amount
of a drug that is effective when taken before a meal may be
ineffective if administered during or after eating.
• Irritating drugs are better tolerated by the patient if food is
present in the stomach to dilute the drug’s concentration. e.g.
Iron, Arsenic and cod liver oil should always be given after
meals
• Antacid drugs taken before meal.
22
22
Environmental Factors
• These factors affect the dose of the drugs due to some
physiological changes in the body functioning.
• Daylight is stimulant, enhancing the effect of stimulating drugs
and diminishing the effect of hypnotics.
• Darkness is sedative. Hypnotics are more effective at night.
• The amount of barbiturate required to produce sleep during
daytime is much higher than the dose required to produce sleep
at night.
• Consumption of alcohol enhances the effect of CNS depressants,
alcohol induces hepatic enzymes and causes rapid metabolism.
23
23
Emotional Factors
• Sometimes emotional factors govern the dose of the drugs.
• Females are more emotional and responsive than males and
require less dose of certain drugs.
• The personality of the doctor may influence the patient for his
early recover; such faith on the mind of the patient may affect
the efficiency of the dose of the drug.
• Inert dosage forms called placebos which resemble the actual
medicament in the physical properties are known to produce
therapeutic benefit in diseases like angina pectoris and
bronchial asthma.
24
24
Presence of Disease
• Higher doses of the drugs can be tolerated in diseased condition
of the patients than in normal patients.
• When there is the condition of hepatic and renal disturbances
the drugs are not metabolized properly and accumulation of
drug can be occurred even if normal dose is given.
• Drugs like barbiturates and chlorpromazine may produce
unusually prolonged effect in patients having liver cirrhosis.
• Streptomycin which is excreted mainly by kidney may prove
toxic for patients having kidney failure.
25
25
Accumulation
• Accumulation of drug in the body is the result of slow excretion,
defective degradation or unexpected rapid absorption of the
drugs.
• The drugs which are slowly excreted may build up a sufficient
high concentration in the body and produce toxic symptoms if it
is repeatedly administered for prolonged time.
• E.g. digitalis, emetine and heavy metals.
26
26
Additive effect
• When the total pharmacological action of two or more drugs
administered together is equivalent to the sum of their
individual pharmacological action. This phenomenon is called
as additive effect
• Ephedrine & aminophylline in the treatment of bronchial
asthma.
• 1+1=2
27
27
Synergism
• When two or more drugs are used in combination form, their
action is increased. This Phenomenon is called synergism.
• E.g. Procaine and adrenaline combination increases the
duration of action of procaine.
• 1+1=3
28
28
Antagonism
• When the action of one drug is opposed by the action of other
drug on the same pharmacological system is known as drug
antagonism.
• The use of antagonistic response to drugs is valuable in the
treatment of poisoning e.g. milk of magnesia is given in acid
poisoning where alkaline effect of milk of magnesia neutralizes
the effect of acid poisoning.
29
29
a) Competitive/Reversible antagonism: Both agonist and
antagonist have same binding site.
Acetylcholine and atropine
b) Noncompetitive/Irreversible antagonism: Antagonist
inactivate receptor so that effector complex with agonist cant
be formed.
Phenoxybenzamine and adrenaline at α-receptor.
c) Physiological antagonism: Binding of agonist and antagonist
to two different receptors but their action is opposite.
Adrenaline (bronchodilatation) and histamine
(bronchoconstriction).
30
30
Idiosyncrasy
• Extraordinary pharmacological response to a drug, which is
different from its characteristic pharmacological action is called
idiosyncrasy.
• The word idiosyncrasy has been replaced by allergy.
• This is the condition when persons do not respond alike to the
same drug due to individual factors.
• Small dose of quinine may cause ringing in ear and small dose
of aspirin may cause gastric hemorrhage.
31
31
Tolerance
• When unusually large dose of drug is required to produce
pharmacological action which could have been otherwise
produced by normal dose, is termed as tolerance.
• e.g., Smokers can tolerate nicotine etc.
• The drug tolerance is of two types:
1. True tolerance is produced by oral and parenteral
administration of drug.
2. Pseudo is produced only by oral route of administration.
32
32
Tachyphylaxis
• It is observed that when certain drugs are administered
repeatedly at short intervals, the cell receptors are blocked up
and pharmacological response to that particular drug is
decreased.
• The decreased response cannot be reversed by increasing the
dose. This phenomenon is known as tachyphylaxis or acute
tolerance.
• e.g., Ephedrine when given in repeated dose at short interval in
the treatment of bronchial asthma may produce very less
response due to tachyphylaxis.
33
33
Hypersensitivity
• It is also called ‘allergic’ reaction of the drug. It is different from
the desired pharmacological action or known toxic effect of the
drug.
• This type of behavior of the drug can be due to frequent or
indiscriminate use of the drugs like antibiotics, vitamins or
some proteinous substances.
• If a person is sensitized by prior administration of the same
drug, a minute dose of the drug will produce allergic reaction.
34
34
Metabolic Distrubances
• Changes in water electrolyte balance and acid base balance,
body temperature and other physiological factors may modify
the effects of drugs.
• Salicylates reduce the body temperature only in case an
individual has rise in body temperature. They have no
antipyretic action
35
35
Drug dependence/ Addiction:
Dependence/Habituation
a. Physical Dependence: Tea, Nicotine
– Depend on drug to function normally
– Occurrence of withdrawal syndrome
– when stop taking drug abruptly
– Vary from one class of drug to another
– Compensating mechanisms produce imbalance
b. Psychological Dependence: LSD, Marijuana, Opiates
– Behavioral dependence
– High rate of drug use, craving for the drug & tendency to relapse
after stopping use
– Related to drug reinforcing properties
THANK YOU

More Related Content

What's hot

Application of preformulation consideration in the development of
Application of preformulation consideration in the development ofApplication of preformulation consideration in the development of
Application of preformulation consideration in the development of
Arpan Dhungel
 
Micromeritics
MicromeriticsMicromeritics
Tablet processing problems and their remedies
Tablet processing problems and their remediesTablet processing problems and their remedies
Tablet processing problems and their remedies
Baharul Islam
 
Ch10. pharmaceutical emulsion
Ch10. pharmaceutical emulsionCh10. pharmaceutical emulsion
Ch10. pharmaceutical emulsion
Bule Hora University
 
Micromeritics 1 - Physical Pharmacy
Micromeritics 1 - Physical PharmacyMicromeritics 1 - Physical Pharmacy
Micromeritics 1 - Physical Pharmacy
AdarshPatel73
 
Test for identification of type of emulsion
Test for identification of type of emulsionTest for identification of type of emulsion
Test for identification of type of emulsion
SantuMistree4
 
Posology
PosologyPosology
Posology
keshob ghosh
 
Prescription
Prescription Prescription
Prescription
Ravikumar Patil
 
State of matter and properties of matter(part 1)
State of matter and properties of matter(part 1)State of matter and properties of matter(part 1)
State of matter and properties of matter(part 1)
Ms. Pooja Bhandare
 
PHYSICAL PHARMACEUTICS II COARSE DISPERSION
PHYSICAL PHARMACEUTICS II COARSE DISPERSION PHYSICAL PHARMACEUTICS II COARSE DISPERSION
PHYSICAL PHARMACEUTICS II COARSE DISPERSION
VijayaKumarR28
 
Deformation of solids (Physical Pharmaceutics)
Deformation of solids (Physical Pharmaceutics)Deformation of solids (Physical Pharmaceutics)
Deformation of solids (Physical Pharmaceutics)
MAYANK ,MEHENDIRATTA
 
Powders and granules
Powders and granulesPowders and granules
Powders and granules
Prof. Dr. Basavaraj Nanjwade
 
Solution-----(Pharmaceutics)
Solution-----(Pharmaceutics)Solution-----(Pharmaceutics)
Solution-----(Pharmaceutics)
Soft-Learners
 
Solubility
SolubilitySolubility
Solubility
Medical Knowledge
 
Colloidal dispersion
Colloidal dispersionColloidal dispersion
Colloidal dispersion
Dipak Bhingardeve
 
Capsule
CapsuleCapsule
Capsule
Kiran Rodge
 
ISOTONICITY
ISOTONICITYISOTONICITY
ISOTONICITY
TAUFIK MULLA
 
solubilization ( physical pharmacy )
solubilization ( physical pharmacy )solubilization ( physical pharmacy )
solubilization ( physical pharmacy )
Samar Aziz
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
ramchoure90
 
Hard gelatin capsules - a detailed study
Hard gelatin capsules - a detailed studyHard gelatin capsules - a detailed study
Hard gelatin capsules - a detailed study
Teny Thomas
 

What's hot (20)

Application of preformulation consideration in the development of
Application of preformulation consideration in the development ofApplication of preformulation consideration in the development of
Application of preformulation consideration in the development of
 
Micromeritics
MicromeriticsMicromeritics
Micromeritics
 
Tablet processing problems and their remedies
Tablet processing problems and their remediesTablet processing problems and their remedies
Tablet processing problems and their remedies
 
Ch10. pharmaceutical emulsion
Ch10. pharmaceutical emulsionCh10. pharmaceutical emulsion
Ch10. pharmaceutical emulsion
 
Micromeritics 1 - Physical Pharmacy
Micromeritics 1 - Physical PharmacyMicromeritics 1 - Physical Pharmacy
Micromeritics 1 - Physical Pharmacy
 
Test for identification of type of emulsion
Test for identification of type of emulsionTest for identification of type of emulsion
Test for identification of type of emulsion
 
Posology
PosologyPosology
Posology
 
Prescription
Prescription Prescription
Prescription
 
State of matter and properties of matter(part 1)
State of matter and properties of matter(part 1)State of matter and properties of matter(part 1)
State of matter and properties of matter(part 1)
 
PHYSICAL PHARMACEUTICS II COARSE DISPERSION
PHYSICAL PHARMACEUTICS II COARSE DISPERSION PHYSICAL PHARMACEUTICS II COARSE DISPERSION
PHYSICAL PHARMACEUTICS II COARSE DISPERSION
 
Deformation of solids (Physical Pharmaceutics)
Deformation of solids (Physical Pharmaceutics)Deformation of solids (Physical Pharmaceutics)
Deformation of solids (Physical Pharmaceutics)
 
Powders and granules
Powders and granulesPowders and granules
Powders and granules
 
Solution-----(Pharmaceutics)
Solution-----(Pharmaceutics)Solution-----(Pharmaceutics)
Solution-----(Pharmaceutics)
 
Solubility
SolubilitySolubility
Solubility
 
Colloidal dispersion
Colloidal dispersionColloidal dispersion
Colloidal dispersion
 
Capsule
CapsuleCapsule
Capsule
 
ISOTONICITY
ISOTONICITYISOTONICITY
ISOTONICITY
 
solubilization ( physical pharmacy )
solubilization ( physical pharmacy )solubilization ( physical pharmacy )
solubilization ( physical pharmacy )
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
 
Hard gelatin capsules - a detailed study
Hard gelatin capsules - a detailed studyHard gelatin capsules - a detailed study
Hard gelatin capsules - a detailed study
 

Similar to POSOLOGY.pptx

Posology 1st sem
Posology 1st semPosology 1st sem
Posology 1st sem
Sridebesh Ghorui
 
Posology
PosologyPosology
Posology.pdf
Posology.pdfPosology.pdf
Posology.pdf
Dr. Harshil Patel
 
posology ppt.pptx
posology ppt.pptxposology ppt.pptx
posology ppt.pptx
KiranKumar837161
 
Dispensing Pharmacy: Posology
Dispensing Pharmacy: PosologyDispensing Pharmacy: Posology
Dispensing Pharmacy: Posology
Parag Jain
 
Posology
PosologyPosology
Posology
Ravikumar Patil
 
2 posology
2 posology2 posology
2 posology
Pradeep Patil
 
Posology.pptx
Posology.pptxPosology.pptx
Posology.pptx
BALASUNDARESAN M
 
Rue
RueRue
Factors affecting drug action in Pharmacology
Factors affecting drug action in PharmacologyFactors affecting drug action in Pharmacology
Factors affecting drug action in Pharmacology
A M O L D E O R E
 
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Pediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptxPediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptx
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Azad Haleem
 
Posology, doses calculations,pharmacist, important topic of pharma, doses cal...
Posology, doses calculations,pharmacist, important topic of pharma, doses cal...Posology, doses calculations,pharmacist, important topic of pharma, doses cal...
Posology, doses calculations,pharmacist, important topic of pharma, doses cal...
RajkumarKumawat11
 
Posology
Posology Posology
Posology
Naina Dubey
 
Geriatric & Pediatrics Pharmacology
Geriatric & Pediatrics Pharmacology  Geriatric & Pediatrics Pharmacology
Geriatric & Pediatrics Pharmacology
Manoj Kumar
 
Posology by nitesh ppt
Posology by nitesh pptPosology by nitesh ppt
Posology by nitesh ppt
NITESH KUMAR
 
Drug use in paediatric & geriatric patients
Drug use in paediatric & geriatric patientsDrug use in paediatric & geriatric patients
Drug use in paediatric & geriatric patients
Viraj Shinde
 
Posology for dosage calculation adults, children, old age patients
Posology for dosage calculation adults, children, old age patientsPosology for dosage calculation adults, children, old age patients
Posology for dosage calculation adults, children, old age patients
Bhavin Pandya
 
pediatrics pharmacology
pediatrics pharmacologypediatrics pharmacology
pediatrics pharmacology
Azad Haleem
 
Posology pdf
Posology pdfPosology pdf
Posology pdf
saeedanwar78
 

Similar to POSOLOGY.pptx (20)

Posology 1st sem
Posology 1st semPosology 1st sem
Posology 1st sem
 
Posology
PosologyPosology
Posology
 
Posology.pdf
Posology.pdfPosology.pdf
Posology.pdf
 
posology ppt.pptx
posology ppt.pptxposology ppt.pptx
posology ppt.pptx
 
Dispensing Pharmacy: Posology
Dispensing Pharmacy: PosologyDispensing Pharmacy: Posology
Dispensing Pharmacy: Posology
 
Posology
PosologyPosology
Posology
 
2 posology
2 posology2 posology
2 posology
 
Posology.pptx
Posology.pptxPosology.pptx
Posology.pptx
 
Rue
RueRue
Rue
 
Factors affecting drug action in Pharmacology
Factors affecting drug action in PharmacologyFactors affecting drug action in Pharmacology
Factors affecting drug action in Pharmacology
 
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Pediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptxPediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptx
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
 
Pharma 2014
Pharma 2014Pharma 2014
Pharma 2014
 
Posology, doses calculations,pharmacist, important topic of pharma, doses cal...
Posology, doses calculations,pharmacist, important topic of pharma, doses cal...Posology, doses calculations,pharmacist, important topic of pharma, doses cal...
Posology, doses calculations,pharmacist, important topic of pharma, doses cal...
 
Posology
Posology Posology
Posology
 
Geriatric & Pediatrics Pharmacology
Geriatric & Pediatrics Pharmacology  Geriatric & Pediatrics Pharmacology
Geriatric & Pediatrics Pharmacology
 
Posology by nitesh ppt
Posology by nitesh pptPosology by nitesh ppt
Posology by nitesh ppt
 
Drug use in paediatric & geriatric patients
Drug use in paediatric & geriatric patientsDrug use in paediatric & geriatric patients
Drug use in paediatric & geriatric patients
 
Posology for dosage calculation adults, children, old age patients
Posology for dosage calculation adults, children, old age patientsPosology for dosage calculation adults, children, old age patients
Posology for dosage calculation adults, children, old age patients
 
pediatrics pharmacology
pediatrics pharmacologypediatrics pharmacology
pediatrics pharmacology
 
Posology pdf
Posology pdfPosology pdf
Posology pdf
 

More from Venugopal N

NDA Application.pptx
NDA Application.pptxNDA Application.pptx
NDA Application.pptx
Venugopal N
 
Investigator Brochure.pptx
Investigator Brochure.pptxInvestigator Brochure.pptx
Investigator Brochure.pptx
Venugopal N
 
IND Application.pptx
IND Application.pptxIND Application.pptx
IND Application.pptx
Venugopal N
 
INCOMPATABILITIES.pptx
INCOMPATABILITIES.pptxINCOMPATABILITIES.pptx
INCOMPATABILITIES.pptx
Venugopal N
 
ICH Q9.pptx
ICH Q9.pptxICH Q9.pptx
ICH Q9.pptx
Venugopal N
 
COPP.pptx
COPP.pptxCOPP.pptx
COPP.pptx
Venugopal N
 
CDSCO.pptx
CDSCO.pptxCDSCO.pptx
CDSCO.pptx
Venugopal N
 
CLINICAL TRIALS.pptx
CLINICAL TRIALS.pptxCLINICAL TRIALS.pptx
CLINICAL TRIALS.pptx
Venugopal N
 
Clinical Trial Protocol.pptx
Clinical Trial Protocol.pptxClinical Trial Protocol.pptx
Clinical Trial Protocol.pptx
Venugopal N
 
Asean singapore
Asean singaporeAsean singapore
Asean singapore
Venugopal N
 
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug MonitoringPHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
Venugopal N
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.
Venugopal N
 

More from Venugopal N (12)

NDA Application.pptx
NDA Application.pptxNDA Application.pptx
NDA Application.pptx
 
Investigator Brochure.pptx
Investigator Brochure.pptxInvestigator Brochure.pptx
Investigator Brochure.pptx
 
IND Application.pptx
IND Application.pptxIND Application.pptx
IND Application.pptx
 
INCOMPATABILITIES.pptx
INCOMPATABILITIES.pptxINCOMPATABILITIES.pptx
INCOMPATABILITIES.pptx
 
ICH Q9.pptx
ICH Q9.pptxICH Q9.pptx
ICH Q9.pptx
 
COPP.pptx
COPP.pptxCOPP.pptx
COPP.pptx
 
CDSCO.pptx
CDSCO.pptxCDSCO.pptx
CDSCO.pptx
 
CLINICAL TRIALS.pptx
CLINICAL TRIALS.pptxCLINICAL TRIALS.pptx
CLINICAL TRIALS.pptx
 
Clinical Trial Protocol.pptx
Clinical Trial Protocol.pptxClinical Trial Protocol.pptx
Clinical Trial Protocol.pptx
 
Asean singapore
Asean singaporeAsean singapore
Asean singapore
 
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug MonitoringPHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.
 

Recently uploaded

CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 

Recently uploaded (20)

CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 

POSOLOGY.pptx

  • 2. 2 2 CONTENTS • Definition • Formulas to calculate Child Dose based on – Age – Body Weight – Body Surface Area • Factors influencing dose
  • 3. 3 3 Definition Posology is derived from the Greek word “Posos” meaning how much “Logos” meaning science. So posology is the branch of medicine dealing with doses. i.e., quantity of drugs which can be administered to a patient to get the desired pharmacological action. The optimum dose of a drug varies from patient to patient.
  • 4. 4 4 Formulas to calculate child dose Based on age: 1. Young’s Formula 2. Dilling’s Formula 3. Fried’s Formula 4. Cowling’s Formula Based on body weight: 1. Clark’s Formula Based on Surface area: 1. Catzel Formula 2. Mosteller Formula
  • 5. 5 5 AGE • Neonate: From birth to till 30 days • Infant: Upto 1 year • Toddler: 1 - 3 years • Child: 3 – 12 years • Adolescent: 13 – 18 years • Adult • Geriatrics
  • 13. Factors Influencing Dose 1. Age 2. Sex 3. Body Weight 4. Route of Administration 5. Time of Administration 6. Environmental Factors 7. Emotional Factors 8. Presence of Disease 9. Accumulation 10. Additive Effect 11. Synergism 12. Antagonism 13. Idiosyncrasy 14. Tolerance 15. Tachyphylaxis 16. Hypersensitivity 17. Metabolic disturbances 18. Drug dependence
  • 14. 14 14 AGE • Age of an individual is one of the important factor affecting the dose and pharmacological action of the drugs. • Age is considered with the capacity of metabolizing or excreting the drugs from the body. • Newborn infants (pediatric) are abnormally sensitive to certain drugs because of the immature state of their hepatic and renal function by which drugs are inactivated and eliminated from the body. • Failure to detoxify and eliminate drugs results in their accumulation in the tissues to a toxic level.
  • 15. 15 15 • The decline in renal and hepatic function in the elderly (geriatric) may slow drug clearance and increases the possibility of drug accumulation in the body and subsequent toxicity. • Elderly individuals may also respond abnormally to the usual amount of a drug because of changes in drug-receptor sensitivity or because of age-related alterations in target tissues and organs. New Born: • Chloramphenicol cause grey baby syndrome because of inadequate metabolism resulting drug accumulation. • Absorption of Amoxycillin is higher because of less gastric acidity.
  • 16. 16 16 Children (Paediatrics): • Need lesser dose than the normal adult dose, because of their pharmacokinetic profile (metabolism & excretion). • Children can tolerate relatively larger amounts of belladonna, digitalis and ethanol whereas, elderly patients are more sensitive to hypnotics and tranquillizers which may produce confusion states in them. • The blood brain barrier (BBB) of children are not well developed so more sensitive to CNS stimulants. Adults: Age (18 yrs), weight (70 kg) and BSA (1.7-1.8 m2 ) Old people (Geriatrics, age > 60 yrs): • Need lesser dose because of their pharmacokinetic profile • More sensitive to diazepam and morphine
  • 17. 17 17 SEX • Sex, either male or females affect the dose of the drugs. • Women do not always respond to the action of the drugs in same manner as it is done in men. • Morphine and barbiturates produce more excitement before sedation in women. Special care must be taken when drugs are administered during menstruation, pregnancy and lactation. • The strong purgatives such as aloes should be avoided during menstruation. • Drugs which may stimulate the uterine smooth muscles e.g. drastic purgatives, antimalarial drugs and ergot alkaloids are contraindicated during pregnancy.
  • 18. 18 18 • During lactation drugs like antihistamines, morphine and tetracycline are excreted in milk, should be avoided or use cautiously. • Alcohol, barbiturate, narcotic drugs acts on fetus through placenta. Because of the undeveloped drug detoxification and excretion mechanisms present in the fetus, concentrations of drugs may reach a higher level in the fetus than in the maternal circulation. • The transfer of drugs from the mother to the nursing infant through human milk may occur with various drugs with the drug effects becoming manifest in the infant.
  • 19. 19 19 Body Weight • Weight of the drug is considered as a key factor on the theory that the concentration of a drug at its site of action will often be influenced by the size of the patient. • The average dose is mentioned either in terms of mg/kg body weight or as total single dose for an adult weighing 70 kg. • However, in cases of obese patients, children and malnourished patients the dose differs. It should be calculated according to the body weight.
  • 20. 20 20 Route of Administration • They are many routes of administration. • Route of administration affects therapeutic efficacy of drug. • Drugs administered intravenously enter the blood stream directly and thus the full amount administered is present in the blood. • In contrast, drugs administered orally are rarely fully absorbed due to the various physical, chemical and biologic barriers to their absorption, including interactions with the gastric and intestinal contents. • Thus, a lesser parentral dose of a drug is required than the oral dose to achieve the same blood levels of drug.
  • 21. 21 21 Time of Administration • The time at which a drug is administered sometimes influences dosage. This is specially true for oral therapy in relation to meals. • The drugs are more rapidly absorbed on empty stomach. • Absorption proceeds more rapidly if the stomach and upper portions of the intestinal tract are free of food, and an amount of a drug that is effective when taken before a meal may be ineffective if administered during or after eating. • Irritating drugs are better tolerated by the patient if food is present in the stomach to dilute the drug’s concentration. e.g. Iron, Arsenic and cod liver oil should always be given after meals • Antacid drugs taken before meal.
  • 22. 22 22 Environmental Factors • These factors affect the dose of the drugs due to some physiological changes in the body functioning. • Daylight is stimulant, enhancing the effect of stimulating drugs and diminishing the effect of hypnotics. • Darkness is sedative. Hypnotics are more effective at night. • The amount of barbiturate required to produce sleep during daytime is much higher than the dose required to produce sleep at night. • Consumption of alcohol enhances the effect of CNS depressants, alcohol induces hepatic enzymes and causes rapid metabolism.
  • 23. 23 23 Emotional Factors • Sometimes emotional factors govern the dose of the drugs. • Females are more emotional and responsive than males and require less dose of certain drugs. • The personality of the doctor may influence the patient for his early recover; such faith on the mind of the patient may affect the efficiency of the dose of the drug. • Inert dosage forms called placebos which resemble the actual medicament in the physical properties are known to produce therapeutic benefit in diseases like angina pectoris and bronchial asthma.
  • 24. 24 24 Presence of Disease • Higher doses of the drugs can be tolerated in diseased condition of the patients than in normal patients. • When there is the condition of hepatic and renal disturbances the drugs are not metabolized properly and accumulation of drug can be occurred even if normal dose is given. • Drugs like barbiturates and chlorpromazine may produce unusually prolonged effect in patients having liver cirrhosis. • Streptomycin which is excreted mainly by kidney may prove toxic for patients having kidney failure.
  • 25. 25 25 Accumulation • Accumulation of drug in the body is the result of slow excretion, defective degradation or unexpected rapid absorption of the drugs. • The drugs which are slowly excreted may build up a sufficient high concentration in the body and produce toxic symptoms if it is repeatedly administered for prolonged time. • E.g. digitalis, emetine and heavy metals.
  • 26. 26 26 Additive effect • When the total pharmacological action of two or more drugs administered together is equivalent to the sum of their individual pharmacological action. This phenomenon is called as additive effect • Ephedrine & aminophylline in the treatment of bronchial asthma. • 1+1=2
  • 27. 27 27 Synergism • When two or more drugs are used in combination form, their action is increased. This Phenomenon is called synergism. • E.g. Procaine and adrenaline combination increases the duration of action of procaine. • 1+1=3
  • 28. 28 28 Antagonism • When the action of one drug is opposed by the action of other drug on the same pharmacological system is known as drug antagonism. • The use of antagonistic response to drugs is valuable in the treatment of poisoning e.g. milk of magnesia is given in acid poisoning where alkaline effect of milk of magnesia neutralizes the effect of acid poisoning.
  • 29. 29 29 a) Competitive/Reversible antagonism: Both agonist and antagonist have same binding site. Acetylcholine and atropine b) Noncompetitive/Irreversible antagonism: Antagonist inactivate receptor so that effector complex with agonist cant be formed. Phenoxybenzamine and adrenaline at α-receptor. c) Physiological antagonism: Binding of agonist and antagonist to two different receptors but their action is opposite. Adrenaline (bronchodilatation) and histamine (bronchoconstriction).
  • 30. 30 30 Idiosyncrasy • Extraordinary pharmacological response to a drug, which is different from its characteristic pharmacological action is called idiosyncrasy. • The word idiosyncrasy has been replaced by allergy. • This is the condition when persons do not respond alike to the same drug due to individual factors. • Small dose of quinine may cause ringing in ear and small dose of aspirin may cause gastric hemorrhage.
  • 31. 31 31 Tolerance • When unusually large dose of drug is required to produce pharmacological action which could have been otherwise produced by normal dose, is termed as tolerance. • e.g., Smokers can tolerate nicotine etc. • The drug tolerance is of two types: 1. True tolerance is produced by oral and parenteral administration of drug. 2. Pseudo is produced only by oral route of administration.
  • 32. 32 32 Tachyphylaxis • It is observed that when certain drugs are administered repeatedly at short intervals, the cell receptors are blocked up and pharmacological response to that particular drug is decreased. • The decreased response cannot be reversed by increasing the dose. This phenomenon is known as tachyphylaxis or acute tolerance. • e.g., Ephedrine when given in repeated dose at short interval in the treatment of bronchial asthma may produce very less response due to tachyphylaxis.
  • 33. 33 33 Hypersensitivity • It is also called ‘allergic’ reaction of the drug. It is different from the desired pharmacological action or known toxic effect of the drug. • This type of behavior of the drug can be due to frequent or indiscriminate use of the drugs like antibiotics, vitamins or some proteinous substances. • If a person is sensitized by prior administration of the same drug, a minute dose of the drug will produce allergic reaction.
  • 34. 34 34 Metabolic Distrubances • Changes in water electrolyte balance and acid base balance, body temperature and other physiological factors may modify the effects of drugs. • Salicylates reduce the body temperature only in case an individual has rise in body temperature. They have no antipyretic action
  • 35. 35 35 Drug dependence/ Addiction: Dependence/Habituation a. Physical Dependence: Tea, Nicotine – Depend on drug to function normally – Occurrence of withdrawal syndrome – when stop taking drug abruptly – Vary from one class of drug to another – Compensating mechanisms produce imbalance b. Psychological Dependence: LSD, Marijuana, Opiates – Behavioral dependence – High rate of drug use, craving for the drug & tendency to relapse after stopping use – Related to drug reinforcing properties